Omrix Biopharmaceuticals, Inc. of NEW YORK, NY filed a SC 14D9 with the SEC on 2008-11-26. Industry: Biological Products, (No Diagnostic Substances).
| Seq | Type | Description |
|---|---|---|
| 1 | SC 14D9 | SCHEDULE 14D9 |
| 2 | EX-99.A.4 | EX-99.A.4: LETTER TO STOCKHOLDERS |
| 3 | EX-99.E.3 | EX-99.E.3: NONDISCLOSURE AGREEMENT |
| 4 | GRAPHIC | GRAPHIC |
Showing 12 of 18 filings.
| Filed | Form |
|---|---|
| 2008-12-29 | SC TO-T/A |
| 2008-12-19 | SC 14D9/A |
| 2008-12-19 | SC 14D9/A |
| 2008-12-19 | SC TO-T/A |
| 2008-12-17 | SC 14D9/A |
| 2008-12-17 | SC TO-T/A |
| 2008-12-17 | SC TO-T/A |
| 2008-12-12 | SC TO-T/A |
| 2008-12-11 | SC 14D9/A |
| 2008-12-05 | SC 14D9/A |
| 2008-12-01 | SC TO-T/A |
| 2008-12-01 | SC 14D9/A |